FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2947739181> ?p ?o ?g. }

• W2947739181 abstract "Catecholamines, especially norepinephrine, are the most frequently used vasopressors for treating patients with septic shock. During the recent decades, terlipressin, vasopressin V1A agonist, and even Ca2+ sensitizer were increasingly used by physicians. The aim of this study is to compare the efficacy of such different kinds of vasoactive medications on mortality among patients with septic shock.Relevant randomized controlled trials were identified by searching PubMed, Embase, Web of Science, and the Cochrane Central Register of Controlled Trials updated to February 22, 2018. A network meta-analysis was performed to evaluate the effect of different types of vasoactive medications. The primary outcome was 28-day mortality. Intensive care unit (ICU) mortality, hospital and ICU length of stay (LOS), and adverse events were also assessed.A total of 43 trials with 5767 patients assessing 17 treatment modalities were included. Treatments ranking based on surface under the cumulative ranking curve values from largest to smallest were NE/DB 85.9%, TP 75.1%, NE/EP 74.6%, PI 74.1%, EP 72.5%, VP 66.1%, NE 59.8%, PE 53.0%, DA 42.1%, DX 38.2%, SP 27.0%, PA 24.3%, EX 22.8%, LE 21.5%, and DB 13.3% for 28-day mortality. Treatments ranking for ICU mortality were TP/NE 86.4%, TP 80.3%, TP/DB/NE 65.7%, VP/NE 62.8%, NE 57.4%, VP 56.5%, PE 48.4%, DA 33.0%, PA 27.5%, LE 22.1%, and DB 9.9%. The incidence of myocardial infarction was reported with NE/EP 3.33% (n = 1 of 30), followed by EP 3.11% (n = 5 of 161), and then VP 3.10% (n = 19 of 613), NE 3.03% (n = 43 of 1417), DA 2.21% (n = 19 of 858), NE/DB 2.01% (n = 4 of 199), LE 1.16% (n = 3 of 258), and PA 0.39% (n = 1 of 257). The incidence of arrhythmia was reported with DA 26.01% (n = 258 of 992), followed by EP 22.98% (n = 37 of 161), and then NE/DB 20.60% (n = 41 of 199), NE/EP 20.0% (n = 6 of 30), NE 8.33% (n = 127 of 1525), LE 5.81% (n = 15 of 258), PA 2.33% (n = 6 of 257), and VP 1.67% (n = 10 of 600).The use of norepinephrine plus dobutamine was associated with lower 28-day mortality for septic shock, especially among patients with lower cardiac output." @default.
• W2947739181 created "2019-06-07" @default.
• W2947739181 creator A5006699474 @default.
• W2947739181 creator A5008750923 @default.
• W2947739181 creator A5048587276 @default.
• W2947739181 creator A5049038727 @default.
• W2947739181 creator A5063697349 @default.
• W2947739181 creator A5072564902 @default.
• W2947739181 creator A5086631113 @default.
• W2947739181 date "2019-05-14" @default.
• W2947739181 modified "2023-10-16" @default.
• W2947739181 title "Comparative efficacy of vasoactive medications in patients with septic shock: a network meta-analysis of randomized controlled trials" @default.
• W2947739181 cites W1081621427 @default.
• W2947739181 cites W1537972189 @default.
• W2947739181 cites W1617328014 @default.
• W2947739181 cites W1630391490 @default.
• W2947739181 cites W1665755696 @default.
• W2947739181 cites W1729155387 @default.
• W2947739181 cites W1818617568 @default.
• W2947739181 cites W1940869776 @default.
• W2947739181 cites W1971874806 @default.
• W2947739181 cites W1992536611 @default.
• W2947739181 cites W1993647014 @default.
• W2947739181 cites W2000396230 @default.
• W2947739181 cites W2005717288 @default.
• W2947739181 cites W2010699829 @default.
• W2947739181 cites W2012281973 @default.
• W2947739181 cites W2015222304 @default.
• W2947739181 cites W2022255724 @default.
• W2947739181 cites W2025155187 @default.
• W2947739181 cites W2028546766 @default.
• W2947739181 cites W2029411057 @default.
• W2947739181 cites W2039207984 @default.
• W2947739181 cites W2042672404 @default.
• W2947739181 cites W2061588724 @default.
• W2947739181 cites W2066473574 @default.
• W2947739181 cites W2069431723 @default.
• W2947739181 cites W2073339003 @default.
• W2947739181 cites W2074147400 @default.
• W2947739181 cites W2075861522 @default.
• W2947739181 cites W2077171622 @default.
• W2947739181 cites W2082430120 @default.
• W2947739181 cites W2083275888 @default.
• W2947739181 cites W2085803274 @default.
• W2947739181 cites W2092576934 @default.
• W2947739181 cites W2095944485 @default.
• W2947739181 cites W2098923148 @default.
• W2947739181 cites W2102372841 @default.
• W2947739181 cites W2104996682 @default.
• W2947739181 cites W2105985116 @default.
• W2947739181 cites W2107328434 @default.
• W2947739181 cites W2108153775 @default.
• W2947739181 cites W2109051507 @default.
• W2947739181 cites W2126516757 @default.
• W2947739181 cites W2128855592 @default.
• W2947739181 cites W2129821518 @default.
• W2947739181 cites W2137978142 @default.
• W2947739181 cites W2141531782 @default.
• W2947739181 cites W2157657037 @default.
• W2947739181 cites W2159933802 @default.
• W2947739181 cites W2165010366 @default.
• W2947739181 cites W2269240082 @default.
• W2947739181 cites W2280404143 @default.
• W2947739181 cites W2282181907 @default.
• W2947739181 cites W2285622542 @default.
• W2947739181 cites W2292699211 @default.
• W2947739181 cites W2346149673 @default.
• W2947739181 cites W2432593977 @default.
• W2947739181 cites W2489536306 @default.
• W2947739181 cites W2495235786 @default.
• W2947739181 cites W2518614997 @default.
• W2947739181 cites W2520487438 @default.
• W2947739181 cites W2529283167 @default.
• W2947739181 cites W2588681363 @default.
• W2947739181 cites W2591424251 @default.
• W2947739181 cites W2594902220 @default.
• W2947739181 cites W2603440970 @default.
• W2947739181 cites W2743830069 @default.
• W2947739181 cites W2745432684 @default.
• W2947739181 cites W2749901817 @default.
• W2947739181 cites W2807293735 @default.
• W2947739181 cites W2989589195 @default.
• W2947739181 cites W3016555942 @default.
• W2947739181 cites W4254170669 @default.
• W2947739181 doi "https://doi.org/10.1186/s13054-019-2427-4" @default.
• W2947739181 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6518735" @default.
• W2947739181 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31088524" @default.
• W2947739181 hasPublicationYear "2019" @default.
• W2947739181 type Work @default.
• W2947739181 sameAs 2947739181 @default.
• W2947739181 citedByCount "27" @default.
• W2947739181 countsByYear W29477391812019 @default.
• W2947739181 countsByYear W29477391812020 @default.
• W2947739181 countsByYear W29477391812021 @default.
• W2947739181 countsByYear W29477391812022 @default.
• W2947739181 countsByYear W29477391812023 @default.
• W2947739181 crossrefType "journal-article" @default.
• W2947739181 hasAuthorship W2947739181A5006699474 @default.
• W2947739181 hasAuthorship W2947739181A5008750923 @default.
• W2947739181 hasAuthorship W2947739181A5048587276 @default.

• next